Kyverna Therapeutics, Inc. Share Price
KYTXKyverna Therapeutics, Inc. Stock Performance
Open $8.10 | Prev. Close $7.81 | Circuit Range N/A |
Day Range $7.77 - $8.22 | Year Range $1.78 - $13.60 | Volume 19,081 |
Average Traded $7.97 |
Kyverna Therapeutics, Inc. Share Price Chart
About Kyverna Therapeutics, Inc.
Kyverna Therapeutics, Inc., clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases. The company's lead product candidate is KYV-101, an autologous CD19 CAR T-cell product candidate for the treatment of stiff person syndrome and myasthenia gravis that is in phase 2 clinical trial; and for lupus nephritis. It is also developing KYV-102, an autologous CD19 CAR T-cell product candidate with whole blood rapid manufacturing, as well as KYV-201, an allogeneic CD19 CAR T-cell product candidate. It has a license and collaboration agreement with Intellia Therapeutics, Inc. The company was formerly known as BAIT Therapeutics, Inc. and changed its name to Kyverna Therapeutics, Inc. in October 2019. Kyverna Therapeutics, Inc. was incorporated in 2018 and is headquartered in Emeryville, California.
Kyverna Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
06-Jan-26 | $8.10 | $7.79 | +0.00% |
06-Jan-26 | $8.10 | $7.79 | -10.97% |
02-Jan-26 | $9.46 | $8.75 | -6.72% |
31-Dec-25 | $9.21 | $9.38 | +0.43% |
30-Dec-25 | $9.26 | $9.34 | -1.37% |
29-Dec-25 | $9.15 | $9.47 | +0.80% |
26-Dec-25 | $8.90 | $9.39 | +4.39% |
FAQs on Kyverna Therapeutics, Inc. Share Price
Can I buy Kyverna Therapeutics, Inc. shares in India?
What is the share price of Kyverna Therapeutics, Inc.?
What is the 5 year returns of Kyverna Therapeutics, Inc.?
What are the high & low stock price of Kyverna Therapeutics, Inc. today?
What is the 52-week high and low of Kyverna Therapeutics, Inc. stock?